Related Experiment Video

Updated: Jul 10, 2026

Systemic Bacterial Infection and Immune Defense Phenotypes in Drosophila Melanogaster
10:12

Systemic Bacterial Infection and Immune Defense Phenotypes in Drosophila Melanogaster

Published on: May 13, 2015

[Two flies with one blow--platencin, an new antibiotic]

Ulrike Holzgrabe1

  • 1Würzburg.

Pharmazie in Unserer Zeit
|October 25, 2007
PubMed

Insights

Researchers discovered Platensimycin, a novel antibiotic that inhibits fatty acid synthesis. This compound disrupts bacterial cell membrane and surface construction, offering a new approach to combating infections.

Area of Science:

  • Microbiology
  • Medicinal Chemistry

Background:

  • Antibiotic resistance is a growing global health concern.
  • Novel mechanisms of action are needed to develop new antibacterial agents.
  • Fatty acid biosynthesis is essential for bacterial survival and proliferation.

Purpose of the Study:

  • To report the discovery of Platensimycin, a novel antibiotic.
  • To investigate the mechanism of action of Platensimycin.
  • To evaluate the potential of Platensimycin as a therapeutic agent against bacterial infections.

Main Methods:

  • Isolation and characterization of Platensimycin.
  • In vitro assays to determine the inhibitory activity against bacterial fatty acid synthesis.
  • Assessment of the impact of Platensimycin on bacterial cell membrane and surface integrity.

Main Results:

  • Platensimycin effectively inhibits bacterial fatty acid biosynthesis.
  • The compound disrupts the construction of bacterial cell membranes and surfaces.
  • Platensimycin demonstrates potent antibacterial activity.

Conclusions:

  • Platensimycin represents a promising new class of antibiotics targeting fatty acid synthesis.
  • Its unique mechanism of action may overcome existing resistance pathways.
  • Further research is warranted to explore the therapeutic potential of Platensimycin.

More Related Videos

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Plague01:24

Plague

Plague is a highly virulent zoonotic disease caused by Yersinia pestis, a Gram-negative, facultatively anaerobic coccobacillus. This pathogen primarily circulates among rodent populations and is transmitted to humans through the bite of infected fleas. Additional transmission routes include direct contact with infected animal tissue or inhalation of respiratory droplets from individuals with pneumonic plague. These multiple transmission pathways highlight the bacterium’s potential for rapid...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...